3.12 USD
↘ 0.05 (1.58%)AT CLOSE (03:59 PM EST)
X4 Pharmaceuticals, Inc. Common Stock
XFORNASDAQ • USD
3.12
↘ 0.01 (0.16%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
3.12
↘ 0.01 (0.16%)
Market: CLOSED
Shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) are trading at $3.12. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, XFOR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Nov 13, 2026.
Open?$3.20
High?$3.20
Low?$2.98
Prev. Close?$3.17
Volume?501.3K
Avg. Volume?701.4K
VWAP?$3.07
Rel. Volume?0.71x
Bid / Ask
Bid?$2.95 × 1.5K
Ask?$3.14 × 300
Spread?$0.19
Midpoint?$3.05
Valuation & Ratios
Market Cap?318.6M
Shares Out?99.1M
Float?80.7M
Float %?81.4%
P/E Ratio?N/A
P/B Ratio?2.29
EPS?-$0.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Employees
45
Market Cap
318.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-11-16
Address
61 NORTH BEACON STREET
BOSTON, MA 02134
Phone: 857-529-8300
BOSTON, MA 02134
Phone: 857-529-8300
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?0
Momentum?98
Short Sent.?43
Piotroski F-Score?5/9Mixed
Altman Z-Score?-2.00Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?9.88%Elevated
Short Interest?8.0M
Days to Cover?10.9
Free Float80.7M
Avg Daily Volume734.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?13.22Strong
Quick Ratio?12.86Strong
Cash Ratio?12.40Strong
Debt/Equity?0.55Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.29CHEAP▾
Peers100
S&P68
P/S?18.78HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
S&P97
EV/Sales?12.37HIGH▾
Peers100
S&P7
Returns & Efficiency
ROE?-58.0%WEAK▾
S&P3
ROA?-34.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-76100000
Enterprise Value?$209.8M
Fundamentals ratios updated end of day